EN | UA
EN | UA

Help Support

Back

Impact of DHFR deletion/insertion polymorphism on people with mild cognitive impairment

Dihydrofolate_reductase Dihydrofolate_reductase
Dihydrofolate_reductase Dihydrofolate_reductase

A pooled study was conducted to investigate the impact of dihydrofolate reductase (DHFR) 19-bp deletion/insertion (del/ins) polymorphism on therapy containing folic acid on brain atrophy and cognitive deficit in elderly patients with mild cognitive impairment (MCI).

See All

Key take away

In geriatrics, the positive impact of folic acid-containing B vitamins on cognitive function is only evident in people with ins/ins genotype, i.e, relatively better preserved activity of dihydrofolate reductase.

Background

A pooled study was conducted to investigate the impact of dihydrofolate reductase (DHFR) 19-bp deletion/insertion (del/ins) polymorphism on therapy containing folic acid on brain atrophy and cognitive deficit in elderly patients with mild cognitive impairment (MCI).

Method

In this study, pooled data was utilized from 2 randomized B-vitamin trials on people with MCI (n=545) who were given either B vitamins including folic acid or a placebo for 24 months. Participants were sorted for the DHFR genotype. The Clinical Dementia Rating scale-global score (CDR-global) was the major endpoint ascertained. The memory and executive Z-scores, whole brain atrophy rate by serial magnetic resonance imaging, and Clinical Dementia Rating-sum of boxes (CDR-SOB) scores were the other endpoints ascertained.

Result

Table 1 shows the proportion of participants with ins/ins, del/ins, and del/del genotype.

The DHFR genotypes altered the impact of B vitamins on executive function Z-scores, CDR-SOB, and CDR-global. Substantial advantages were noted in people with ins/ins genotype. Folic acid-containing supplementation elicited improvement in cognitive performance over a two-year period only in people without DHFR 19-bp deletion allele (ins/ins genotype). The interaction was not meaningful for whole brain atrophy rate and memory Z-score. Only the brain atrophy was slowed by the supplements in people with 'ins/ins' genotype who were not utilizing aspirin.

Conclusion

DHFR 19-bp deletion polymorphism demonstrated substantial interaction effects with folic acid-containing B-vitamin supplementation in geriatrics with MCI. Compared to people with del allele(s), people with ins/ins genotype were more likely to experience improvement in cognitive function.

Source:

Human Molecular Genetics

Article:

The dihydrofolate reductase 19-bp deletion modifies the beneficial effect of B-vitamin therapy in mild cognitive impairment: pooled study of two randomized placebo-controlled trials

Authors:

Yuanyuan Wu et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: